These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24469251)

  • 1. Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.
    Tortoriello G; Morris CV; Alpar A; Fuzik J; Shirran SL; Calvigioni D; Keimpema E; Botting CH; Reinecke K; Herdegen T; Courtney M; Hurd YL; Harkany T
    EMBO J; 2014 Apr; 33(7):668-85. PubMed ID: 24469251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal cannabinoid receptors and the "dis-joint-ed" brain.
    Cristino L; Di Marzo V
    EMBO J; 2014 Apr; 33(7):665-7. PubMed ID: 24631837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
    Laaris N; Good CH; Lupica CR
    Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
    Miller S; Daily L; Leishman E; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5904-5911. PubMed ID: 30550613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons.
    de Salas-Quiroga A; Díaz-Alonso J; García-Rincón D; Remmers F; Vega D; Gómez-Cañas M; Lutz B; Guzmán M; Galve-Roperh I
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13693-8. PubMed ID: 26460022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects.
    Ellgren M; Artmann A; Tkalych O; Gupta A; Hansen HS; Hansen SH; Devi LA; Hurd YL
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):826-34. PubMed ID: 18674887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SCG10 is a JNK target in the axonal degeneration pathway.
    Shin JE; Miller BR; Babetto E; Cho Y; Sasaki Y; Qayum S; Russler EV; Cavalli V; Milbrandt J; DiAntonio A
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):E3696-705. PubMed ID: 23188802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic memory of Δ9-tetrahydrocannabinol exposure in pluripotent stem cells and primordial germ cells-like cells.
    Verdikt R; Armstrong AA; Cheng J; Hwang YS; Clark AT; Yang X; Allard P
    Elife; 2023 Dec; 12():. PubMed ID: 38150302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
    Lombard C; Hegde VL; Nagarkatti M; Nagarkatti PS
    J Pharmacol Exp Ther; 2011 Nov; 339(2):607-17. PubMed ID: 21831965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic dissection of behavioural and autonomic effects of Delta(9)-tetrahydrocannabinol in mice.
    Monory K; Blaudzun H; Massa F; Kaiser N; Lemberger T; Schütz G; Wotjak CT; Lutz B; Marsicano G
    PLoS Biol; 2007 Oct; 5(10):e269. PubMed ID: 17927447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity.
    Fan N; Yang H; Zhang J; Chen C
    J Neurochem; 2010 Feb; 112(3):691-702. PubMed ID: 19912468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats.
    Di Bartolomeo M; Stark T; Maurel OM; Iannotti FA; Kuchar M; Ruda-Kucerova J; Piscitelli F; Laudani S; Pekarik V; Salomone S; Arosio B; Mechoulam R; Maccarrone M; Drago F; Wotjak CT; Di Marzo V; Vismara M; Dell'Osso B; D'Addario C; Micale V
    Pharmacol Res; 2021 Feb; 164():105357. PubMed ID: 33285233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex.
    Downer EJ; Gowran A; Campbell VA
    Brain Res; 2007 Oct; 1175():39-47. PubMed ID: 17884022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Δ9-tetrahydrocannabinol prompts rapid changes in cannabinoid CB
    Bonilla-Del Río I; Puente N; Mimenza A; Ramos A; Serrano M; Lekunberri L; Gerrikagoitia I; Christie BR; Nahirney PC; Grandes P
    J Comp Neurol; 2021 Jun; 529(9):2332-2346. PubMed ID: 33368252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex.
    Saez TM; Aronne MP; Caltana L; Brusco AH
    J Neurochem; 2014 May; 129(4):637-48. PubMed ID: 24329778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.
    Sousa VC; Assaife-Lopes N; Ribeiro JA; Pratt JA; Brett RR; Sebastião AM
    Neuropsychopharmacology; 2011 Jan; 36(2):472-87. PubMed ID: 20927050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.